Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Exchange Rate Effect (2023 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Exchange Rate Effect for 3 consecutive years, with $1230.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect fell 30.82% to $1230.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $6575.0, a 88.4% decrease, with the full-year FY2024 number at $499.0, down 99.19% from a year prior.
  • Exchange Rate Effect was $1230.0 for Q3 2025 at 60 Degrees Pharmaceuticals, down from $17242.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $54175.0 in Q4 2023 to a low of -$9904.0 in Q1 2025.
  • A 3-year average of $6447.3 and a median of $1230.0 in 2025 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 1021.07% in 2025; the steepest drop was 1101.94% in 2025.
  • 60 Degrees Pharmaceuticals' Exchange Rate Effect stood at $54175.0 in 2023, then crashed by 103.68% to -$1993.0 in 2024, then skyrocketed by 161.72% to $1230.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Exchange Rate Effect are $1230.0 (Q3 2025), $17242.0 (Q2 2025), and -$9904.0 (Q1 2025).